Rapid Fire Abstracts
Zhan-Qiu Liu, PhD
Research Scientist
Stanford University
Zhan-Qiu Liu, PhD
Research Scientist
Stanford University
Vicky Y. Wang, PhD
Research Fellow
The University of Auckland, New Zealand
Michael Loecher, PhD
Research Scientist
Stanford University
Ian Y. Chen, MD, PhD
Assistant Professor
Veterans Affairs Palo Alto Health Care System
Sachin Malik, MD
Radiologist
Palo Alto Veteran Affairs Medical Center
Daniel B. Ennis, PhD
Professor
Stanford University
HFpEF patients (N=6, 72±16 years old) and healthy controls (N=7, 62±7 years old), were prospectively enrolled in an IRB-approved study, consented, and underwent a 3T (Skyra/Vida, Siemens) CMR exam. Single-slice, short-axis, mid-ventricular data was acquired using breath-hold cine DENSE (2x2x8 mm3, TE/TRes=1.08/15ms, ke=0.08cycles/mm, Navg=1, ~20s/slice)7. Global radial (Err) and circumferential strains (Ecc) were computed using the DENSE analysis tool8,9. The systolic strain rate was defined as the slope of the strain curve from the 1st cardiac frame to 90% of the peak-systolic strain (Line A in Fig. 1). The early-diastolic strain rate was defined as the slope over the duration from 90% of the end-systole to mid-diastole (Line B in Fig. 1). LV volumes and function were calculated from standard bSSFP cine images. Group-wise differences were tested by a Wilcoxon rank-sum test. Data is reported as median (IQR) and p< 0.05 was considered significant. Lastly, a binomial logistic regression model tested whether Ecc, systolic Ecc/s, and early-diastolic Ecc/s can distinguish between healthy controls and HFpEF patients. HFpEF patients exhibited significantly reduced Ecc and Ecc/s compared to healthy controls, which has been observed previously using echocardiography speckle tracking5,10. The impairment may be indicative of a compensatory mechanism employed by HFpEF hearts to sustain normal ejection fraction. Ecc, systolic Ecc/s, and early-diastolic Ecc/s could be used to distinguish HFpEF patients from healthy controls and may serve as non-invasive biomarkers with high reproducibility for screening HFpEF patients.
Results: HFpEF patients were significantly heavier, resulting in significantly higher BMI and BSA compared to healthy controls (Table 1). HFpEF patients had significantly lower LVEDVi compared to healthy controls [68(28) vs 96(23), p=0.024]. There was no statistically significant difference in Err, systolic Err/s, and early-diastolic Err/s between HFpEF patients and healthy controls (Fig. 2). However, HFpEF patients exhibited significantly impaired Ecc [-0.14(0.04) vs -0.19(0.04), p=0.011], systolic Ecc/s [-0.56(0.09) vs -0.75(0.16), p=0.014], and early-diastolic Ecc/s [0.39(0.14) vs 0.92(0.35), p=0.001] compared to healthy controls (Figure 2). Early-diastolic Ecc/s best distinguished between HFpEF patients and healthy controls (AUC=1), followed by a combination of Ecc and systolic Ecc/s (AUC=0.98), and Ecc (AUC=0.88).
Conclusion: